References
- Broderick J P, Brott T, Tomsick T, Miller R, Huster G. Intracerebral haemorrhage more than twice as common as subarachnoid haemorrhage. J Neurosurg 1993; 78: 188–91
- Adams H P, Jr, Kassell N F, Torner J C, Nibbelink D W, Sahs A L. Early management of aneurysmal subarachnoid haemorrhage. A report of the cooperative aneurysm study. J Neurosurg 1981; 54: 141–5
- Treggiari-Venzi M M, Suter P M, Romand J A. Review of medical prevention of vasospasm after aneurysmal subarachnoid haemorrhage: a problem of neurointensive care. Neurosurgery 2001; 48: 249–61, discussion 261–2
- Biller J, Godersky J C, Adams H P, Jr. Management of aneurysmal subarachnoid haemorrhage. Stroke 1988; 19: 1300–5
- Harrod C G, Bendok B R, Batjer H H. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid haemorrhage: a review. Neurosurgery 2005; 56: 633–54, discussion 633–54
- Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001; 70: 534–7
- Bavbek M, Polin R, Kwan A L, et al. Monoclonal antibodies against icam-1 and cd18 attenuate cerebral vasospasm after experimental subarachnoid haemorrhage in rabbits. Stroke 1998; 29: 1930–5, discussion 1935–6
- Okada T, Harada T, Bark D H, Mayberg M R. A rat femoral artery model for vasospasm. Neurosurgery 1990; 27: 349–56
- Fiszer U, Korczak-Kowalska G, Palasik W, et al. Increased expression of adhesion molecule cd18 (lfa-1beta) on the leukocytes of peripheral blood in patients with acute ischemic stroke. Acta Neurol Scand 1998; 97: 221–4
- Lindsberg P J, Carpen O, Paetau A, Karjalainen-Lindsberg M L. Kaste M. Endothelial icam-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996; 94: 939–45
- Conklin D J, Trent M B, Boor P J. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: Mechanisms of myocardial protection and aortic medial injury in rats. Toxicology 1999; 138: 137–54
- Tomitori H, Usui T, Saeki N, et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 2005; 36: 2609–13
- Firlik K S, Kaufmann A M, Firlik A D, Jungreis C A, Yonas H. Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. Surg Neurol 1999; 51: 66–74
- Schoch B, Regel J P, Wichert M, et al. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid haemorrhage. Neurosurgery 2007; 60: 828–36, discussion 828–36
- Polin R S, Bavbek M, Shaffrey M E, et al. Detection of soluble e-selectin, icam-1, vcam-1, and l-selectin in the cerebrospinal fluid of patients after subarachnoid haemorrhage. J Neurosurg 1998; 89: 559–67
- Park C C, Shin M L, Simard J M. The complement membrane attack complex and the bystander effect in cerebral vasospasm. J Neurosurg 1997; 87: 294–300
- Conklin D J, Boyce C L, Trent M B, Boor P J. Amine metabolism: a novel path to coronary artery vasospasm. Toxicol Appl Pharmacol 2001; 175: 149–59